WAM
Werlinich Asset Management’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.3M | Hold |
17,760
| – | – | 1.8% | 17 |
|
|
2025
Q1 | $3.72M | Hold |
17,760
| – | – | 2.36% | 12 |
|
|
2024
Q4 | $3.13M | Buy |
17,760
+110
| +0.6% | +$19.4K | 1.82% | 16 |
|
|
2024
Q3 | $3.49M | Hold |
17,650
| – | – | 2.02% | 13 |
|
|
2024
Q2 | $2.98M | Buy |
17,650
+25
| +0.1% | +$4.23K | 1.86% | 15 |
|
|
2024
Q1 | $3.18M | Sell |
17,625
-25
| -0.1% | -$4.51K | 2.08% | 13 |
|
|
2023
Q4 | $2.73M | Sell |
17,650
-417
| -2% | -$64.6K | 2.07% | 15 |
|
|
2023
Q3 | $2.69M | Buy |
18,067
+507
| +3% | +$75.6K | 2.22% | 14 |
|
|
2023
Q2 | $2.37M | Hold |
17,560
| – | – | 1.9% | 19 |
|
|
2023
Q1 | $2.8M | Buy |
17,560
+50
| +0.3% | +$7.97K | 2.46% | 12 |
|
|
2022
Q4 | $2.83M | Hold |
17,510
| – | – | 2.62% | 14 |
|
|
2022
Q3 | $2.35M | Sell |
17,510
-150
| -0.8% | -$20.1K | 2.4% | 14 |
|
|
2022
Q2 | $2.7M | Hold |
17,660
| – | – | 2.53% | 12 |
|
|
2022
Q1 | $2.86M | Sell |
17,660
-400
| -2% | -$64.8K | 2.18% | 14 |
|
|
2021
Q4 | $2.45M | Hold |
18,060
| – | – | 1.78% | 18 |
|
|
2021
Q3 | $1.95M | Buy |
18,060
+100
| +0.6% | +$10.8K | 1.58% | 24 |
|
|
2021
Q2 | $2.02M | Hold |
17,960
| – | – | 1.63% | 21 |
|
|
2021
Q1 | $1.94M | Buy |
+17,960
| New | +$1.94M | 1.71% | 22 |
|